Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 20, 2026 07:00 ET | Source: AtaiBeckley N.V.

AtaiBeckley To Host Virtual Investor Day on March 6, 2026

AtaiBeckley will host a Virtual Investor Day on Friday, March 6, 2026, from 9:00 a.m. to 12:00 p.m. ET.
February 18, 2026 08:28 ET | Source: Orion Energy Systems, Inc.

Orion to Present at Emerging Growth Conference on February 26, 2026

Orion to Present at Emerging Growth Conference on February 26, 2026
February 18, 2026 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference

aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
February 17, 2026 07:01 ET | Source: Pasithea

Pasithea Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Pasithea Therapeutics (Nasdaq: KTTA) will present to Oppenheimer 36th Annual Healthcare Life Sciences Conference on Thursday, February 25, 2026, 4:00 PM ET
February 17, 2026 07:00 ET | Source: AtaiBeckley N.V.

AtaiBeckley To Participate in Upcoming Investor Conferences

Srinivas Rao, Co-Founder and Chief Executive Officer, and Jason Awe, VP of Investor Relations, will participate in several investor conferences.
February 17, 2026 02:00 ET | Source: Pharming Group N.V.

Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference

Pharming to attend and present at Oppenheimer 36th Annual Healthcare Life Sciences Conference. CEO & CMO to present on February 25 at 12:40pm ET/18:40 CET.
February 12, 2026 16:05 ET | Source: TheRas, Inc. (d/b/a BBOT)

BBOT to Participate in Upcoming Investor Healthcare Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on RAS-pathway...
February 05, 2026 08:00 ET | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026

FLORHAM PARK, N.J., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
January 22, 2026 16:00 ET | Source: Arcutis Biotherapeutics, Inc.

Arcutis to Report Fourth Quarter and Full Year 2025 Financial Results and Present at Upcoming Investor Conference

Fourth quarter and full year 2025 investor conference call scheduled for February 25, 2026 at 4:30 p.m. ETArcutis management to present at the Guggenheim Emerging Outlook: Biotech Summit on February...
January 13, 2026 16:15 ET | Source: INVO Fertility, Inc.

INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and...